Who We Are

elisabetta-profile-photo-13

ELISABETTA FINESCHI Elisabetta founded Biotexcel Ltd in 2011 and started the business as a consulting firm that specialised in providing technical and commercial consulting to life science companies. Through the consulting business, Elisabetta struck up a collaboration with a client and this led to the first genomic event called NGS 2013 Oxford which was held as a partnership. This event then led to multiple collaborations across Europe with NHS and University genomic labs and resulted in a portfolio of several Europe-wide genomic events.

ed-profile-photo-9

ED QUAZI Ed who has a PhD in Genetics looks after strategic relationships with Biotexcel partners. These partnerships with NHS and University genomic groups has led to the evolution of our NGS events in Europe. Ed is responsible for bringing together genomics based biomarker discovery, clinical and engineering groups to form research consortia which then apply for international funding for non-invasive diagnostic workflows. Ed uses his experience from these ventures to run workshops at all our genomic events. Ed also manages the consulting side of the business.

aeroportogaleao-kevin

KEVIN BLIGHE Kevin Blighe who has a PhD has vast experience in Clinical Genomics & Bioinformatics. He has worked in many countries in Europe and North & South America and is also the founder of the Clinical Bioinformatics Company Ltd. Kevin has worked with Biotexcel Ltd in multiple capacities and is now a non-executive director, a scientific advisor as well as a key partner in our Research Consortia business.

nikolai-3

NIKOLAI ZHELEV Nikolai has the role of non-executive director as well as being partner in our Genomic Events business – he brings a wealth of experience and knowledge to us. Nikolai is Professor of Medical Biotechnology at University of Abertay, Dundee in addition to being the director of CMBCR and head of Cancer Systems biology. Nikolai is a distinguished academic as well as having worked in a senior level position in the Pharma industry, being head of department at Cyclacel. Currently Nikolai is honorary professor in eight universities in the UK, Bulgaria and China as well as the honorary consul general for Bulgaria in Scotland.